Ocular Therapeutix, Inc.
OCUL
$11.92
$0.342.94%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 349.68M | 392.10M | 427.22M | 459.69M | 482.89M |
| Total Receivables | 25.22M | 32.56M | 30.65M | 30.23M | 26.55M |
| Inventory | 3.27M | 3.04M | 2.41M | 2.55M | 2.57M |
| Prepaid Expenses | 9.52M | 13.28M | 12.74M | 6.12M | 7.67M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | 150.00K |
| Total Current Assets | 387.69M | 440.99M | 473.01M | 498.59M | 519.82M |
|
|
|||||
| Total Current Assets | 387.69M | 440.99M | 473.01M | 498.59M | 519.82M |
| Net Property, Plant & Equipment | 16.61M | 15.33M | 15.74M | 16.89M | 17.51M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.61M | 1.61M | 1.61M | 1.61M | 1.61M |
| Total Assets | 405.92M | 457.94M | 490.37M | 517.09M | 538.95M |
|
|
|||||
| Total Accounts Payable | 4.63M | 4.18M | 4.00M | 3.69M | 6.45M |
| Total Accrued Expenses | 31.08M | 35.12M | 30.45M | 23.15M | 16.04M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.16M | 1.93M | 1.72M | 1.66M | 1.54M |
| Total Finance Division Other Current Liabilities | 64.00K | 128.00K | 190.00K | 1.48M | 263.00K |
| Total Other Current Liabilities | 64.00K | 128.00K | 190.00K | 1.48M | 263.00K |
| Total Current Liabilities | 37.93M | 41.35M | 36.36M | 29.97M | 24.30M |
|
|
|||||
| Total Current Liabilities | 37.93M | 41.35M | 36.36M | 29.97M | 24.30M |
| Long-Term Debt | 69.20M | 68.51M | 67.82M | 67.13M | 66.46M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 4.87M | 5.35M | 5.59M | 6.10M | 6.41M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 28.00M | 27.39M | 28.58M | 36.19M | 33.80M |
| Total Liabilities | 139.99M | 142.59M | 138.35M | 139.40M | 130.96M |
|
|
|||||
| Common Stock & APIC | 1.22B | 1.21B | 1.19B | 1.18B | 1.17B |
| Retained Earnings | -955.14M | -891.08M | -842.70M | -806.20M | -762.43M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 265.93M | 315.34M | 352.02M | 377.70M | 407.98M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 265.93M | 315.34M | 352.02M | 377.70M | 407.98M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 265.93M | 315.34M | 352.02M | 377.70M | 407.98M |
|
|
|||||